An interventional study of Auditory Cueing in Cerebral Palsy and Children, sponsored by Institute of Child Health. Completed. Open to participants aged 5 Years to 11 Years. Per ClinicalTrials.gov, last updated 2016-08-31.
Sponsored by Institute of Child Health · Not applicable, Interventional, and Treatment
To determine the clinical efficacy of auditory cueing using a cross over design to investigate whether increasing auditory cueing frequency by 20% above self paced cadence affects gait parameters in children with Cerebral Palsy when performing a functional task.
Introduction: Cerebral Palsy is a non progressive disorder occurring in early brain development, resulting in inefficient ambulatory pattern. The use of sensory cues to facilitate loco-motor activity has been suggested as providing the necessary trigger to synchronise movement with greater beneficial outcomes observed at higher frequency intensities within the adult population. Thus auditory cueing could have the potential to alter gait parameters during a functional task.
Aim: To explore if increasing auditory cueing frequency (AC20) affects gait during a functional task compared to auditory cueing at self-paced cadence (ACSC).
Method: Nineteen children with CP levels 1 and 2 on the Gross Motor Function Classification Scale participated using paired analysis. Outcomes were compared to the mean values for temporal spatial gait data within the conditions using a cross over design. TS data was obtained by using the GAITRite® walkway system whilst walking holding a cup.
1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.
This study's enrollment of 19 is below the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Institute of Child Health is the lead sponsor of 40 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants performed a functional task with auditory cueing set at self paced cadence.
Device: Auditory Cueing
Participants performed a functional task with auditory cueing set at 20% above self paced cadence whilst performing a functional task.
Device: Auditory Cueing
Auditory cueing set at different frequency rates
Step Length as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of length was recorded in centimetres.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Velocity as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of velocity was recorded in cm's per second.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Step Time as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of step time was recorded in seconds.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Cadence as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of cadence was recorded in steps per minute.
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Time Spent in Double Support as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Time Spent in Single Support as Measured by the Gaitrite Walk-way System.
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
Time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.
Recruitment occurred at an NHS FoundationTrust between March to April 2015. Twenty-six children with Cerebral Palsy who were currently on the paediatric physiotherapy caseload met the inclusion criteria, so were invited to participate. A total of nineteen children chose to participate in this research project.
| Milestone | Cueing Self Paced Then Cueing 20% Above Self Paced Cadence | Cueing at 20% Above Self Paced Cadence Then Self Based Cadence |
|---|---|---|
| Started | 8 | 11 |
| Completed | 8 | 11 |
| Not completed | 0 | 0 |
| Milestone | Cueing Self Paced Then Cueing 20% Above Self Paced Cadence | Cueing at 20% Above Self Paced Cadence Then Self Based Cadence |
|---|---|---|
| Started | 8 | 11 |
| Completed | 8 | 11 |
| Not completed | 0 | 0 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of length was recorded in centimetres.
| cm | ACSC | AC20 |
|---|---|---|
| Step Length as Measured by the Gaitrite Walk-way System. | 51.32 ± 6.42 | 53.36 ± 8.07 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of velocity was recorded in cm's per second.
| cm/s | ACSC | AC20 |
|---|---|---|
| Velocity as Measured by the Gaitrite Walk-way System. | 98.62 ± 16.29 | 101.77 ± 21.08 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of step time was recorded in seconds.
| seconds | ACSC | AC20 |
|---|---|---|
| Step Time as Measured by the Gaitrite Walk-way System. | 0.53 ± 0.09 | 0.52 ± 0.08 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of cadence was recorded in steps per minute.
| steps per minute | ACSC | AC20 |
|---|---|---|
| Cadence as Measured by the Gaitrite Walk-way System. | 115.27 ± 15.75 | 117.09 ± 15.97 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
| percentage of time | ACSC | AC20 |
|---|---|---|
| Time Spent in Double Support as Measured by the Gaitrite Walk-way System. | 0.30 ± 0.91 | 0.29 ± 0.09 |
The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).
| percentage of time | ACSC | AC20 |
|---|---|---|
| Time Spent in Single Support as Measured by the Gaitrite Walk-way System. | 0.38 ± 0.05 | 0.39 ± 0.05 |
Collected over Two months on completion of the study. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Auditory Cueing at Self Paced Cadence | — | 0/19 (0%) | 0/19 (0%) |
| Cueing at 20% Above Self Paced Cadence | — | 0/19 (0%) | 0/19 (0%) |
| Age, Categorical(Participants) | All Study Participants |
|---|---|
| <=18 years | 19 |
| Between 18 and 65 years | 0 |
| >=65 years | 0 |
| Age, Continuous(months) | All Study Participants |
|---|---|
| Mean | 104.3 ± 25.5 |
| Sex: Female, Male(Participants) | All Study Participants |
|---|---|
| Female | 11 |
| Male | 8 |
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institute of Child Health